Does the immobilizing effect of thiopental in brain exceed that of halothane?

Joseph F. Antognini, Earl Carstens, Richard Atherley

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background: Recent studies suggest that anesthetics such as isoflurane act in the spinal cord to suppress movement that occurs during noxious stimulation. The authors examined the effect of halothane and thiopental on suppression of noxious-evoked movement using a model of differential anesthetic delivery. They hypothesized that halothane and thiopental, similar to isoflurane, would suppress movement primarily via an action in spinal cord. Methods: Goats were anesthetized and prepared for differential anesthetic delivery. Anesthesia was maintained with halothane (n = 5) or thiopental (n = 5). Anesthetic requirements were determined (noxious clamp on a dewclaw for 1 min) during halothane or thiopental (via infusion) delivery to the whole body and delivery only to the head. Results: Control (whole body) halothane requirement was 0.9 ± 0.2%; halothane requirement in the head during differential delivery was 3.4 ± 1% (P < 0.01). During selective halothane delivery, the electroencephalogram was greatly depressed or was isoelectric even though the animals moved during noxious stimulation. Control (whole body) plasma thiopental requirement was 20 ± 10 μg/ml. When thiopental was selectively delivered to the head, the electroencephalogram was active in all five animals, and cranial thiopental requirement was 42 ± 6 μg/ml (P < 0.01). Conclusion: These data suggest that halothane and thiopental, like isoflurane, act in spinal cord to suppress movement occurring with noxious stimulation. However, halothane appears to be less potent in the brain as evidenced by the electroencephalogram data, suggesting that action in spinal cord plays a more significant role for halothane than for thiopental.

Original languageEnglish (US)
Pages (from-to)980-986
Number of pages7
JournalAnesthesiology
Volume96
Issue number4
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Thiopental
Halothane
Brain
Anesthetics
Isoflurane
Spinal Cord
Electroencephalography
Head
Goats
Anesthesia

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Does the immobilizing effect of thiopental in brain exceed that of halothane? / Antognini, Joseph F.; Carstens, Earl; Atherley, Richard.

In: Anesthesiology, Vol. 96, No. 4, 2002, p. 980-986.

Research output: Contribution to journalArticle

Antognini, Joseph F. ; Carstens, Earl ; Atherley, Richard. / Does the immobilizing effect of thiopental in brain exceed that of halothane?. In: Anesthesiology. 2002 ; Vol. 96, No. 4. pp. 980-986.
@article{9051449de2c84cf7a9d16bb2a843d720,
title = "Does the immobilizing effect of thiopental in brain exceed that of halothane?",
abstract = "Background: Recent studies suggest that anesthetics such as isoflurane act in the spinal cord to suppress movement that occurs during noxious stimulation. The authors examined the effect of halothane and thiopental on suppression of noxious-evoked movement using a model of differential anesthetic delivery. They hypothesized that halothane and thiopental, similar to isoflurane, would suppress movement primarily via an action in spinal cord. Methods: Goats were anesthetized and prepared for differential anesthetic delivery. Anesthesia was maintained with halothane (n = 5) or thiopental (n = 5). Anesthetic requirements were determined (noxious clamp on a dewclaw for 1 min) during halothane or thiopental (via infusion) delivery to the whole body and delivery only to the head. Results: Control (whole body) halothane requirement was 0.9 ± 0.2{\%}; halothane requirement in the head during differential delivery was 3.4 ± 1{\%} (P < 0.01). During selective halothane delivery, the electroencephalogram was greatly depressed or was isoelectric even though the animals moved during noxious stimulation. Control (whole body) plasma thiopental requirement was 20 ± 10 μg/ml. When thiopental was selectively delivered to the head, the electroencephalogram was active in all five animals, and cranial thiopental requirement was 42 ± 6 μg/ml (P < 0.01). Conclusion: These data suggest that halothane and thiopental, like isoflurane, act in spinal cord to suppress movement occurring with noxious stimulation. However, halothane appears to be less potent in the brain as evidenced by the electroencephalogram data, suggesting that action in spinal cord plays a more significant role for halothane than for thiopental.",
author = "Antognini, {Joseph F.} and Earl Carstens and Richard Atherley",
year = "2002",
doi = "10.1097/00000542-200204000-00028",
language = "English (US)",
volume = "96",
pages = "980--986",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Does the immobilizing effect of thiopental in brain exceed that of halothane?

AU - Antognini, Joseph F.

AU - Carstens, Earl

AU - Atherley, Richard

PY - 2002

Y1 - 2002

N2 - Background: Recent studies suggest that anesthetics such as isoflurane act in the spinal cord to suppress movement that occurs during noxious stimulation. The authors examined the effect of halothane and thiopental on suppression of noxious-evoked movement using a model of differential anesthetic delivery. They hypothesized that halothane and thiopental, similar to isoflurane, would suppress movement primarily via an action in spinal cord. Methods: Goats were anesthetized and prepared for differential anesthetic delivery. Anesthesia was maintained with halothane (n = 5) or thiopental (n = 5). Anesthetic requirements were determined (noxious clamp on a dewclaw for 1 min) during halothane or thiopental (via infusion) delivery to the whole body and delivery only to the head. Results: Control (whole body) halothane requirement was 0.9 ± 0.2%; halothane requirement in the head during differential delivery was 3.4 ± 1% (P < 0.01). During selective halothane delivery, the electroencephalogram was greatly depressed or was isoelectric even though the animals moved during noxious stimulation. Control (whole body) plasma thiopental requirement was 20 ± 10 μg/ml. When thiopental was selectively delivered to the head, the electroencephalogram was active in all five animals, and cranial thiopental requirement was 42 ± 6 μg/ml (P < 0.01). Conclusion: These data suggest that halothane and thiopental, like isoflurane, act in spinal cord to suppress movement occurring with noxious stimulation. However, halothane appears to be less potent in the brain as evidenced by the electroencephalogram data, suggesting that action in spinal cord plays a more significant role for halothane than for thiopental.

AB - Background: Recent studies suggest that anesthetics such as isoflurane act in the spinal cord to suppress movement that occurs during noxious stimulation. The authors examined the effect of halothane and thiopental on suppression of noxious-evoked movement using a model of differential anesthetic delivery. They hypothesized that halothane and thiopental, similar to isoflurane, would suppress movement primarily via an action in spinal cord. Methods: Goats were anesthetized and prepared for differential anesthetic delivery. Anesthesia was maintained with halothane (n = 5) or thiopental (n = 5). Anesthetic requirements were determined (noxious clamp on a dewclaw for 1 min) during halothane or thiopental (via infusion) delivery to the whole body and delivery only to the head. Results: Control (whole body) halothane requirement was 0.9 ± 0.2%; halothane requirement in the head during differential delivery was 3.4 ± 1% (P < 0.01). During selective halothane delivery, the electroencephalogram was greatly depressed or was isoelectric even though the animals moved during noxious stimulation. Control (whole body) plasma thiopental requirement was 20 ± 10 μg/ml. When thiopental was selectively delivered to the head, the electroencephalogram was active in all five animals, and cranial thiopental requirement was 42 ± 6 μg/ml (P < 0.01). Conclusion: These data suggest that halothane and thiopental, like isoflurane, act in spinal cord to suppress movement occurring with noxious stimulation. However, halothane appears to be less potent in the brain as evidenced by the electroencephalogram data, suggesting that action in spinal cord plays a more significant role for halothane than for thiopental.

UR - http://www.scopus.com/inward/record.url?scp=0036204910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036204910&partnerID=8YFLogxK

U2 - 10.1097/00000542-200204000-00028

DO - 10.1097/00000542-200204000-00028

M3 - Article

C2 - 11964608

AN - SCOPUS:0036204910

VL - 96

SP - 980

EP - 986

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 4

ER -